Cargando…

Different Effects on Fluid Distribution between Tolvaptan and Furosemide in a Liver Cirrhosis Patient with Chronic Kidney Disease

A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagayama, Izumi, Masuda, Takahiro, Nakagawa, Saki, Murakami, Takuya, Ohara, Ken, Matsuoka, Ryo, Kobayashi, Takahisa, Maeshima, Akito, Akimoto, Tetsu, Saito, Osamu, Muto, Shigeaki, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599930/
https://www.ncbi.nlm.nih.gov/pubmed/30713322
http://dx.doi.org/10.2169/internalmedicine.2174-18
Descripción
Sumario:A 73-year-old man with liver cirrhosis and advanced chronic kidney disease was admitted to our hospital due to bilateral lower leg edema and appetite loss. Furosemide to treat fluid retention markedly decreased extracellular water compared with intracellular water, but the addition of tolvaptan equally decreased both with a greater diuretic response than furosemide alone. Furthermore, tolvaptan administration increased the plasma colloid osmotic pressure, which might facilitate the shift of fluid from the extravascular space to the intravascular space. This is the first case showing different effects on the fluid distribution between furosemide and additional tolvaptan in the same patient.